Home>Topics>Stocks>Pharmaceutical Product Development

Pharmaceutical Product Development PPDI

  1. All
  2. Commentary
  3. Stock Reports
  4. Fund Reports
  5. Headlines
    1. New Morningstar Analyst Report for Parexel International Corporation

      Stock Reports

      Mon, 21 Oct 2013

      infrastructure that enables it to compete for complex global trials against larger rivals such as Quintiles and Pharmaceutical Product Development . Parexel also offers consulting and medical communication services to assist clients throughout all

    2. Diamond Hill Long-Short Fund Fourth Quarter Commentary

      Headlines

      Wed, 1 Feb 2012

      saturation. Eliminated Positions We eliminated our long positions in Pharmaceutical Product Development , Inc. and KLA-Tencor Corp. Pharmaceutical Product Development was acquired by two private equity firms while KLA-Tencor was eliminated

    3. Diamond Hill Research Opportunities Fund Fourth Quarter Commentary

      Headlines

      Wed, 1 Feb 2012

      Advent Software, Inc. Eliminated Positions We eliminated our long positions in Assurant, Inc. , Pharmaceutical Product Development , Inc. , Bristol-Myers Squibb Co. , Wal-Mart Stores, Inc. , National Penn Bancshares, Inc

    4. LPC-PPD to launch $1.325 bln buyout loan to retail syndication

      Headlines

      Fri, 4 Nov 2011

      NEW YORK, Nov 4 (LPC) - Pharmaceutical Product Development (PPD) is launching on November 8 at 10 a.m. the retail syndication of its buyout loan, sources said.

    5. New Morningstar Analyst Report - Pharmaceutical Product Development , Inc.

      Stock Reports

      Mon, 3 Oct 2011

      barrier to change for the company. Pharmaceutical Product Development is a global contract research organization ..... While economic uncertainty has sent Pharmaceutical Product Development 's cancellation rate soaring

    6. PPD to Become a Private Company; Deal Value Close to our Fair Value Estimate

      Commentary

      Mon, 3 Oct 2011

      Pharmaceutical Product Development PPDI announced today that it will be acquired by private equity groups The Carlyle Group and Hellman & Friedman for $3.9 billion

    7. PPD Names New CEO

      Commentary

      Mon, 19 Sep 2011

      Pharmaceutical Product Development PPDI announced that it had hired an outsider as its key leader. Raymond H. Hill joined PPD as chief executive officer and a member

    8. Earnings Expansion, Strong Bookings in PPD's Second Quarter Signal Return to Growth for CRO Industry

      Commentary

      Wed, 27 Jul 2011

      Pharmaceutical Product Development PPDI turned in solid second-quarter results that fell in line with our expectations. The firm's strong earnings and new bookings

    9. PPD's Shares Rise on Buyout Rumors

      Commentary

      Mon, 18 Jul 2011

      Pharmaceutical Product Development 's PPDI shares rose sharply Monday on reports that the firm was putting itself up for sale. The company has declined to provide much detail

    « Prev12345Next »
    Content Partners